Navigation Links
Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy
Date:10/30/2012

MONTREAL, Oct. 30, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has decided to reschedule its webcast and conference call to discuss financial results for the 2012 third quarter, which was previously scheduled for Wednesday, October 31, 2012 at 8 a.m. ET, due to the severe weather conditions and power outages associated with Hurricane Sandy. The webcast and conference call has been rescheduled for November 2, 2012 at 8 a.m. ET and the financial results will be issued at 6:00 a.m. ET.

The dial-in number to participate on this call is (877) 281-0402, confirmation code 39252322.  International callers should dial (631) 813-4869, confirmation code 39252322. A replay will be available approximately two hours following the conclusion of the conference call to Friday, November 9, 2012, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 39252322.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
2. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
3. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
4. Valeant Pharmaceuticals To Syndicate Incremental Loans
5. Valeant Pharmaceuticals Announces Management Change
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
8. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
9. Valeant Pharmaceuticals To Host Investor Day
10. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
11. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... PLYMOUTH MEETING, Pa. , Dec. 15, 2014 ... ) announced today it has been added to ... the NASDAQ Biotechnology Index will become effective upon ... The NASDAQ Biotechnology Index is designed to track ... that are classified as either biotechnology or pharmaceutical ...
(Date:12/15/2014)... 2014  Stephen Squires, CEO and founder of leading ... (OTCQB:QTMM), will be speaking at the launch event ... December 16th, 2014. The RCQM launch continues Rice University,s ... top faculty and students and by inviting the world,s ... "We have a long association with Rice ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and ... the addition of the "Drug Injection Devices ... http://photos.prnewswire.com/prnh/20130307/600769 ... of an expanding list of health conditions, drug ... that simplify the administration process and increase the ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... March 1, 2011 Syndax Pharmaceuticals, a clinical-stage ... (NCI) will sponsor a multi-center phase 2 study ... of histone deacetylases (HDAC), and anastrozole, an aromatase ... breast cancer to evaluate biomarkers and surrogates for ...
... Conn., March 1, 2011 To kick off ... products and the Colon Cancer Alliance (CCA) have teamed ... the fears of the colonoscopy. Colon cancer is 90 percent ... avoid getting a colonoscopy—the colon cancer screening test that could ...
Cached Medicine Technology:Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 2Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 3Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 2Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 3Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 5
(Date:12/15/2014)... Grants Pass, OR (PRWEB) December 15, 2014 ... factors perceived by United States women as impacting skin ... – the “Four C’s of skin care.” Water and ... the conclusions in a recent article describing the survey ... her experience, every item in every category discussed would ...
(Date:12/15/2014)... CARSON CITY, NV (PRWEB) December 15, 2014 ... new powerhouse company, JM Ocean Avenue. JM Ocean ... technology of the Veretekk online automated marketing system. ... by the June 2014 merger of Ocean Avenue and ... a more than $2 Billion per year company. , ...
(Date:12/15/2014)... December 15, 2014 South Florida’s leading urgent ... holidays can be a daze of hassle, hustle, and bustle ... while decking halls, to burns when making special meals and ... that can happen at any time. To prevent this season ... has made a list of helpful and healthful holiday tips ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... large, new study should reassure the millions of American women ... for breast cancer. "There is no association between migraine ... associate professor of medicine at Harvard Medical School. "There is ... and there is no protective effect either." About 18 ...
Breaking Medicine News(10 mins):Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... University Of Pennsylvania School Of Medicine suggest that the human ... akin to an Ethernet// connection, which is one of the ... a comparison of neural systems with artificial ones, as ... the available information. These findings have been presented in the ...
... study on the Gender Impact of HIV and AIDS in India ... girl child is also the most likely one to be withdrawn// ... with AIDS. The National AIDS Control Organisation (NACO) estimates that women ... in India in 2005. ,This means that women make up 39 ...
... of California, San Diego (UCSD) School of Medicine, the ... created// and tested molecular therapy in animals which they ... sclerosis (ALS), or Lou Gehrig's disease. The study has ... of therapeutic molecules known as antisense oligonucleotides to the ...
... the researchers for US it was found that tomosyn plays ... The protein gets its name from the Japanese language //because ... team. This protein binds to syntaxin another protein which is ... tomosyn, tomo meaning friend in Japanese. Better understanding of the ...
... the researchers at the University of Southampton it was ... child's susceptibility to atherosclerosis. // ,The study analysed ... lower the mother's calorific intake during pregnancy, the thicker ... to measure the thickness of the wall of the ...
... Cedars-Sinai Medical Center this week launched an International Stem ... embryonic stem cell research. // ,The academic medical ... geneticist Nissim Benvenisty, M.D., Ph.D., as the institute’s co-director ... Research and Scientific Affairs at Cedars-Sinai. ,“This ...
Cached Medicine News:Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 2Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 3Health News:Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis 2Health News:Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis 3Health News:Study Shows Tomosyn Plays an Important Role in Learning and Memory 2Health News:Center Launches New International Stem Cell Research Institute 2
... Tip Ureteral Stents combine a unique polymer ... remembering its shape with a chemically bonded ... The result is a stent that satisfies ... patient comfort. Lubri-Flex® is available in a ...
All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
... ambulatory ECG technology - Until now, if ... Holter on some of your patients while ... the majority of patients, you had to ... Now, all that has changed with Lifecard ...
The Pathfinder HSV 1 and 2 kit provides direct antigen detection and differentiation of Herpes Simplex Virus (HSV) Types 1 and 2. The monoclonal antibody-based test can be used to directly stain cli...
Medicine Products: